Your browser doesn't support javascript.
loading
Exposure-Response Analysis of Osimertinib in EGFR Mutation Positive Non-Small Cell Lung Cancer Patients in a Real-Life Setting.
Boosman, René J; Jebbink, Merel; Veldhuis, Wouter B; Groenland, Stefanie L; van Veggel, Bianca A M H; Moeskops, Pim; de Langen, Adrianus J; Beijnen, Jos H; Smit, Egbert F; Huitema, Alwin D R; Steeghs, Neeltje.
Afiliación
  • Boosman RJ; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute - Antoni Van Leeuwenhoek, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. r.boosman@nki.nl.
  • Jebbink M; Department of Thoracic Oncology, The Netherlands Cancer Institute - Antoni Van Leeuwenhoek, Amsterdam, The Netherlands. m.jebbink@nki.nl.
  • Veldhuis WB; Department of Radiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Groenland SL; Department of Medical Oncology and Clinical Pharmacology, The Netherlands Cancer Institute - Antoni Van Leeuwenhoek, Amsterdam, The Netherlands.
  • van Veggel BAMH; Department of Thoracic Oncology, The Netherlands Cancer Institute - Antoni Van Leeuwenhoek, Amsterdam, The Netherlands.
  • Moeskops P; , Quantib, Rotterdam, The Netherlands.
  • de Langen AJ; Department of Thoracic Oncology, The Netherlands Cancer Institute - Antoni Van Leeuwenhoek, Amsterdam, The Netherlands.
  • Beijnen JH; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute - Antoni Van Leeuwenhoek, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.
  • Smit EF; Department of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
  • Huitema ADR; Department of Thoracic Oncology, The Netherlands Cancer Institute - Antoni Van Leeuwenhoek, Amsterdam, The Netherlands.
  • Steeghs N; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute - Antoni Van Leeuwenhoek, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.
Pharm Res ; 39(10): 2507-2514, 2022 Oct.
Article en En | MEDLINE | ID: mdl-35978149

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares / Antineoplásicos Tipo de estudio: Observational_studies Límite: Humans Idioma: En Revista: Pharm Res Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares / Antineoplásicos Tipo de estudio: Observational_studies Límite: Humans Idioma: En Revista: Pharm Res Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos